Joel Bergstein is the Executive Chairman of Lincoln Equities Group (LEG), one of the Northeast's leading full-service real estate companies.
Bergstein joined the company more than 32 years ago, spearheading the organization’s acquisition and development initiatives. He currently leads the firm’s large scale development platform, orchestrating major residential and industrial land development projects in the New York / New Jersey metro area.
Bergstein developed LEG’s current operating partner platform, leveraging domestic and international opportunities with private equity and pension funds. Bergstein is a founding partner and active participant in LEG’s $700M European property investment platform.
Some of his standout development projects include Halletts Point in Astoria, NY, where LEG transformed a seven acre waterfront site into 2,400 residential apartment units; 5 Giralda in Madison, NJ, a 431,000 square-foot property, that was modernized to become Allergan’s U.S. headquarters; and in early 2018, LEG closed on a 152 acre waterfront site in Bayonne, NJ, where 1.4M square-feet of e-commerce logistics warehousing will be developed to bolster trade with the Port of New York and New Jersey.
Lincoln has formed a partnership with Bruce Eichner’s Continuum Company to develop a mixed-income residential complex in Crown Heights, NY. It will be a 50/50 market and workforce development project to bring hundreds of needed housing units for middle and working class families in New York City. Bergstein is also leading the development and approval process for 1,500 new residential units in Jersey City including the construction of a light rail station.
Bergstein serves on numerous real estate advisory boards and is a speaker and frequent commentator in real estate trade and business media in addition to his philanthropic work.
Contact:
jbergstein@lincolnequities.com